Technology seems to have found its place in the courtrooms also, these days. Viacom, an American global mass media company, sued YouTube, a video-sharing site owned by Google on the basis that YouTube had indulged in rampant intentional copyright infringement…
It seems like all is not well in the kingdom of the King of Good Times. Vijay Mallya, who is already facing a host of financial difficulties, with his airlines accumulating losses and statutory authorities putting pressure on the management…
Ever wondered what is the never-ending excruciating agreement that pops up just before you are all set to make an e-mail account, install an application or download software? Apparently, all of us click the “I agree” option without paying much…
Indian Trade Marks Registry has on 03rd November 2011, published on their website Gazette Notification dated October 13, 2011, which states that after the expiry of forty-five days from the date (which falls on 18 Dec 2011) on which this…
On 18 October 2011, the European Court of Justice (ECJ) gave its decision in Brustle v Greenpeace (C-34/10) regarding the patentability of human embryonic stem cells (hESCs) in Europe. This Decision is largely in view with the Opinion of the…
An Ex-Parte Interim Injunction was recently passed against Symed Laboratories Ltd. (a Hyderabad based Pharmaceutical Company) by Delhi High Court in a patent infringement suit filed by Vifor (International) AG (a Swiss Pharmaceutical Company). The lawsuit was filed by Vifor…
INTRODUCTION For harmonizing IPRs at the international level, providing a common forum for negotiation and resolving disputes between members state we need a single global institution. Earlier WIPO was the main forum for international negotiations of IPR and then WTO…
ESPN Software India, the sole licensee of TV channels ESPN, Star Sports and Star Cricket in India, has filed an FIR against Mr. Pradeep.P, representing Varnam Cable Network (a franchise of Asianet Satellite Communications Ltd.) in Konni, Kerala under the…
Natco Pharma has filed India’s first Compulsory Licensing (CL) Application (in accordance with Section 84(1) of the Indian Patents Act) against one of the Bayer’s patented drug Sorafenib, marketed by Bayer as Nexavar for treating Kidney and Liver Cancer. Patent…
As the title suggests, this article will ride you through interesting judgment given by Division Bench of Kolkata High Court recently in Tea Board, India vs. I.T.C. Limited upholding emphatically the earlier decision of the Single Judge. This is a…